Unilife +13.1% AH, strikes drug delivery supply agreement with Novartis

Shares of Unilife (UNISjump 13.1% AH after the company strikes an injectable drug delivery device supply agreement with Novartis for one of the latter's targeted early-stage pipeline drugs. Terms are confidential.

Under the agreement, Unilife will supply Novartis with a customized syringe, needle, tubing, controller and pump device to administer a clinical trial drug into a targeted organ.

From other sites
Comments (2)
  • smallcap sleuth
    , contributor
    Comments (204) | Send Message
    Verifies the quality and dependability of UNIS. If N believes you'd have to be crazy to think U is flaky! Means nothing EPSwise butbcredibilitywise gold handshake!
    2 Dec 2013, 08:02 PM Reply Like
  • smallcap sleuth
    , contributor
    Comments (204) | Send Message
    The beauty of this announcement is that the delivery system has been closely evaluated by N and it approves. That is one heck of an indorse ment. The financial value will take years if ever but the N endorsement is TODAY and I think significant, and this company NEEDS the credibility this gives. The Pres spending his own money is a nice secondary endorsement but all kinds of funniness can be attached to that but not the Novartis inclusion. That stands ALONE.
    2 Dec 2013, 08:06 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs